Dear Sir,
In Western communities, approximately one out of four subjects have arterial hypertension (AH). 1 Half of them are aware of their hypertension and 50% of them are treated with antihypertensive medication. Nevertheless, only 25% of these individuals achieve adequate blood pressure (BP) management. 2 The inadequate BP control among hypertensives has been attributed in many cases to the limited access to medical care and financial barriers to obtain medication. 3, 4 Most research has focused on patients' noncompliance with recommended therapies or the way in which physicians actually treat patients with AH. 5, 6 At each step from detection through long-term follow-up, large numbers of patients fall out of care. 7 The intensive management of AH is characterized by treatment according to specific stepped care protocols in response to the therapeutic effect. This is considered to provide substantial reduction in cardiovascular mortality. 8 In this intensive context, patient compliance refers to the willingness and ability of an individual patient to follow health-related advice, to take medication as prescribed, to attend scheduled clinic appointments and to complete recommended investigation. 9 In the present study, we investigated the extent and the reasons of poor patients' adherence with the scheduled protocol of clinical attendance in an outpatient BP clinic following an intensive principle.
The present study included individuals who had their first attendance between 1990 and 1999. A total of 968 subjects, 429 males and 539 females, mean age 52.8 7 14.2 years, with AH were included. In the first visit, the medical history of each individual was recorded using a standard questionnaire. In the initial visit, a detailed informational session was also included, during which hypertensives were informed about the vulnerability of target organs and the long-term risk associated with uncontrolled AH. After the diagnosis of AH and the initiation of antihypertensive treatment, each patient was programmed for re-evaluation visits aiming at an individualized therapeutic goal. The management of AH and the intensification of treatment, when needed, followed the stepped care principle. Follow-up visits were scheduled every 4 weeks until adequate control of BP was reached and every 3 months thereafter. Subjects with at least three consecutive missing visits for a period of more than 1 year were characterized as lost to follow-up. The above cohort was contacted by telephone by physicians of our department. A standardized questionnaire was used, which included information about their health status, level of BP control, current antihypertensive treatment, reasons of missing visits and cardiovascular events. These were coded as death, myocardial infarction, cerebrovascular accident, angina pectoris and intermittent claudication.
Statistical analysis was performed using SPSS for Windows version 8.0 (SPSS Inc., Chicago, IL, USA). Values are presented as mean 7 1 s.d. Student's t-test and Mann-Whitney U-test, where applicable, were used for evaluating continuous variables. Differences in dichotomous variables were evaluated using w 2 test. A P-value less than 0.05 was considered statistically significant.
A total of 686 hypertensive subjects (70.9%), 297 males and 389 females, mean age 52.9 7 13.8 years, were compliant to scheduled visits and have already been followed for a mean period of 4.3 7 3.1 years (group A). The remaining 282 hypertensives (29.1%), 132 males and 150 females, mean age 52.6 7 13.6 years, failed to present to the clinic for three or more consecutive visits and for a period exceeding 1 year (group B). Out of them, 108 subjects were lost after the initial visit, while the remaining 174 were lost after a mean of 2.9 7 1.1 visits (range: 2-7). Groups A and B did not differ significantly according to age or gender. Additionally, the two groups were similar in respect to their AH severity. A significant number of hypertensives in both groups were characterized by the coexistence of other cardiovascular risk factors in addition to AH. However, the two groups did not differ significantly according to the prevalence of these risk factors (Table 1) . With respect to the socioeconomic characteristics, the two groups were comparable in terms of high-school graduation and profession.
In group A, 302 subjects (44.0%) were aware of their AH for a period of at least 1 year before their first attendance and 157 of them (51.9%) were already under antihypertensive medication at their initial visit. The remaining 384 group A hypertensives (55.9%) had AH diagnosed within the last year and only 111 (28.9%) of them were receiving medication. In group B, 136 subjects (48.2%) were aware of the presence of AH, a proportion that did not differ significantly from group A (P ¼ NS). However, only 36 (26.5%) of them were under treatment and this difference was significant in comparison with group A with known AH (Po0.001). Moreover, only 28 (19.2%) of the remaining 146 group B individuals, who were aware of their AH for less than 1 year, were under antihypertensive medication. This difference was also significant in comparison with group A subjects with known AH for less than 1 year (P ¼ 0.03).
In their last visit, 684 group A (99.7%) and 273 (96.8%) group B subjects were prescribed antihypertensive medication. Controlled BP was achieved in 425 subjects of group A (61.9%) and 79 of group B (45.4%) who had more than one visit in the outpatient clinic (Po0.001).
The mean period of lost to follow-up for group B subjects was 3.1 7 1.6 years. According to the information collected after telephone calls to all group B subjects, 120 of them had good BP control (42.6%). This proportion was significantly lower than that of group A (61.9 vs 42.6%, P ¼ 0.03). In all, 128 lost to follow-up individuals (45.4%) were still receiving the prescribed medication from the clinic, 95 (33.7%) had changed their medication, while 59 (20.9%) had stopped any drug treatment. The reported reasons for changing or stopping medication were: 'lack of hypertensive symptoms' in 52 subjects (18.4%), inadequate control of their BP in 49 (17.4%), side effects in 41 (14.5%), fear of longterm adverse effects of medication in 35 (12.4%), consultation from their general practitioner for nonhypertension-related reasons in 29 (10.3%) and combination of the above or various other reasons in 76 subjects (27%). The main reasons for cessation of regular attendance at the BP clinic were, again, 'lack of symptoms' in 139 subjects (49.3%) and the convenience of visiting their own physician in 85 (30.1%). During the lost-to-follow-up period, a total of 24 major events were reported in group B after a mean of 2.3 7 1.0 years (range: 0.9-3.6 years) from the initial visit. These were one death, 10 cases of cerebrovascular accidents, six of acute myocardial infarction, five of angina pectoris and two of intermittent claudication. In contrast, in group A, a number of 19 major events were recorded and specifically two deaths, five myocardial infarctions, six cerebrovascular accidents, four cases of angina pectoris and two of intermittent claudication. These events occurred after a mean period of 2.1 7 1.2 years (range: 1.1-3.7 years). The difference in the occurrence of cardiovascular events between the two groups was statistically significant (w 2 ¼ 14.19, Po0.001, odds ratio 3.26; 95% confidence interval, 1.76-6.1).
After the telephone calls and within a period of 6 months, 104 of the 282 group B subjects (36.9%) returned to the BP clinic and 86 of them (82.7%) had poor BP control. Of these subjects, 92 (88.5%) are under regular follow-up thereafter.
Our results suggest that approximately one out of three individuals who are aware of their AH and the majority of whom deliberately choose to be treated in a BP clinic with intensive care management cease their attendance. Furthermore, 20% of them stop their antihypertensive medication. Compliance is the extent to which a person's behaviour in terms of keeping appointments, taking medications and executing lifestyle changes coincides with medical advice and the individuals' personality. 5 The demographic characteristics, the socioeconomic status and the severity of arterial hypertension cannot predict the adherence to follow-up and treatment in this Greek hypertensive population. Poor control of AH has been attributed to several reasons and it has been reported that approximately half of the patients who are prescribed antihypertensive medication discontinue therapy by the end of the first year. 10 Factors that have been associated with inadequate adherence to an intensive care antihypertensive programme are patient's age, gender, knowledge, attitude and beliefs, adverse effects of the drugs, physician-patient relationship and the organization of the health-care delivery system. 5, 11, 12 However, In the present study, subjects who were lost to follow-up suffered significantly more cardiovascular events than the individuals who were compliant with the follow-up programme. The telephone contact with the hypertensives that had been lost for more than 1 year and the reminding of the importance for good BP control resulted in a significant proportion of subjects who returned to the BP clinic for re-evaluation. A specific characteristic of the hypertensives that tend not to adhere to the follow-up programme is that only a small proportion of them was under antihypertensive medication, even when they were aware of the existence of AH for a long period. This may indicate a personality feature that may be used to recognize these patients and probably to apply a different physician-patient approach.
In conclusion, intensive management of hypertensive individuals is limited by the fact that a significant number of them are noncompliant with close follow-up, and this results in inadequate control of their BP. The active physician attitude to contact with these subjects, even after a long period of time, may improve patient compliance and further reduce the cardiovascular risk.
